dr. wang on the evolution of treatment in mcl
Published 4 years ago • 215 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:08
dr. wang discusses the future of treatment in mcl
-
1:28
dr. goy on the evolution of treatment selection in mcl
-
1:15
dr. wang on the pace of progress in mcl
-
0:47
dr. wang on the safety profile of kte-x19 in mcl
-
0:54
dr. wang on updated data with single-agent acalabrutinib in mcl
-
2:19
dr. wang on the fda approval of brexucabtagene autoleucel in mcl
-
0:51
dr. wang on precision medicine in mcl
-
1:04
dr. wang on the safety profile of brexucabtagene autoleucel in relapsed/refractory mcl
-
17:26
doctors die-logues: dr tan yia swam
-
33:18
doctors' die-logues: professor john eu-li wong
-
27:54
the seven ages of a spine surgeon - michael wang, m.d.
-
1:59
dr. wang on ongoing research in mcl
-
1:51
dr. wang on research trends in mcl
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl
-
1:33
dr. dean on the evolution of treatment approaches in mcl
-
1:20
dr. goy the evolution of treatment in relapsed/refractory mcl
-
1:29
dr. wang on the utility of car t-cell therapy in relapsed/refractory mcl
-
1:19
dr. wang on unique properties of kte-x19 in relapsed/refractory mcl
-
1:31
dr. wang on the efficacy of kte-x19 in low- and high-risk r/r mcl
-
1:58
dr. wang on car t-cell therapy resistance in mcl
-
0:58
dr. wang on correlative data from the zuma-2 trial in mcl
-
1:20
dr. wang on the safety and efficacy of kte-x19 in r/r mcl